Glooko and Novo Nordisk have debuted their first offering in the field of digital disease management.
The app, Cornerstones4Care (C4C) is powered by Glooko’s digital diabetes management platform and helps patients sync blood glucose and activity data from a range of diabetes devices and fitness wearables.
The new app identifies any pertinent trends that can help in understanding the factors impacting blood glucose levels; it includes relevant content and resources culled from Cornerstones4Care, a personalized diabetes support program. The integrated offering is intended to help people learn how to better manage diabetes through their mobile devices.
To gain experience and invite use, Novo Nordisk is making the new C4C app free to all patients enrolled in Cornerstones4Care.com and free for download from both the Apple and Google Play App stores.
While Glooko brings its technology to the table, Novo Nordisk contributes a wealth of diabetes knowledge and its Digital Health Platform, developed in collaboration with IBM Watson.
“More people than ever are using mobile apps for chronic disease management, and the apps, like the new C4C app, go beyond data capture or tracking to providing insights and recommendations based on that data,” said Glooko CEO Rick Altinger in the statement.
“Ultimately our
digital health solution will help health care practitioners gain round-the-clock insight into their patients, and empower people with diabetes to better manage their diabetes, with the aim of ultimately leading to better diabetes management outcomes.”The app is the result of a deal between the two companies forged earlier this year with an aim to develop digital products to help people better manage their diabetes.
Glooko’s platform is used in over 4,800 health systems across 27 countries. Late last year, the company merged with Swedish diabetes management company, Diasend, to expand their technological capabilities and establish a greater global footprint.
